ketoconazole has been researched along with fesoterodine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Malhotra, B; Sachse, R; Wood, N | 1 |
| Malhotra, B; Oishi, M; Tomono, Y; Yamagami, H | 1 |
| Chiba, K; Malhotra, B; Oishi, M; Takano, Y; Torita, Y | 1 |
| Goosen, TC; Lin, J; Malhotra, B; Tse, S; Yamagami, H | 1 |
1 review(s) available for ketoconazole and fesoterodine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for ketoconazole and fesoterodine
| Article | Year |
|---|---|
Population pharmacokinetics of the 5-hydroxymethyl metabolite of tolterodine after administration of fesoterodine sustained release tablet in Western and East Asian populations.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Benzhydryl Compounds; Creatinine; Cresols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Female; Genotype; Humans; Ketoconazole; Liver Diseases; Male; Middle Aged; Models, Biological; Muscarinic Antagonists; Rifampin; Tablets; Urinary Bladder, Overactive; Urological Agents; White People; Young Adult | 2014 |
Physiological based pharmacokinetic modeling to estimate in vivo Ki of ketoconazole on renal P-gp using human drug-drug interaction study result of fesoterodine and ketoconazole.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzhydryl Compounds; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Ketoconazole; Kidney; Liver; Male; Models, Biological; Muscarinic Antagonists | 2018 |
2 other study(ies) available for ketoconazole and fesoterodine
| Article | Year |
|---|---|
Evaluation of drug-drug interactions with fesoterodine.
Topics: Antifungal Agents; Area Under Curve; Benzhydryl Compounds; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Evaluation, Preclinical; Drug Interactions; Humans; Ketoconazole; Muscarinic Antagonists; Placebos | 2009 |
Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron.
Topics: Acetanilides; Adult; Benzhydryl Compounds; Cresols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Male; Middle Aged; Rifampin; Thiazoles; Urinary Bladder, Overactive | 2019 |